March 10, 2022 Comments Off on New patent for Abbvie Inc drug MAVYRET Posted in: Patent Added Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are seven patents…
The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWat…
March 9, 2022 Comments Off on New patent for Alkermes Inc drug LYBALVI Posted in: Patent Added Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent for Alkermes Inc drug LYBALVI appeared first on DrugPatent…